TrialMaster

TrialMaster (the flagship clinical product of the massive Anju Software conglomerate) is a fiercely robust, highly mature platform that built its reputation by being incredibly adept at handling "Phase 1 / Oncology and Highly Complex" trial designs that completely break simpler software platforms. Its signature feature is "Complex Adaptive Trial Design." In a simple trial, half the patients get the drug, half get the placebo. In a massive Oncology trial, the design is "Adaptive." If a patient's tumor shrinks by 10% on Day 14, they are mathematically moved to a different dosing group, but if their white blood cell count drops, they are moved to a third group. TrialMaster handles this terrifying, mid-trial mathematical branching logic flawlessly. It also features an incredible "eLearning and Certification Engine." In a global trial, you cannot legally let a doctor draw blood for the study until they have officially passed a training course on the specific protocol. TrialMaster tracks this natively. If Dr. Smith's certification expires on Tuesday, the system physically locks Dr. Smith out of entering patient data on Wednesday, creating a massive, automated legal shield for the Pharma sponsor.